The multifactorial pathways towards resistance to the cytosine analogues emtricitabine and lamivudine: evidences from literature.
University of Rome Tor Vergata, Department of Experimental Medicine and Surgery, Rome, Italy.
Valentina
V
Svicher
University of Rome Tor Vergata, Department of Experimental Medicine and Surgery, Rome, Italy.
Claudia
C
Alteri
University of Rome Tor Vergata, Department of Experimental Medicine and Surgery, Rome, Italy.
Maria Mercedes
MM
Santoro
University of Rome Tor Vergata, Department of Experimental Medicine and Surgery, Rome, Italy.
Francesca
F
Ceccherini-Silberstein
Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, F-75013 Paris, France; INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, F-75013 Paris, France.
Anne-Genevieve
AG
Marcelin
Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, F-75013 Paris, France; INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, F-75013 Paris, France.
Vincent
V
Calvez
University of Rome Tor Vergata, Department of Experimental Medicine and Surgery, Via Montpellier 1, 00133 Rome, Italy. Electronic address: cf.perno@uniroma2.it.
Carlo Federico
CF
Perno
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D008297:Male
D019380:Anti-HIV Agents